Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

NCT06184009 ·Status: RECRUITING ·Phase: PHASE2

Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

NCT00003793 ·Status: COMPLETED

Panitumumab in Children With Solid Tumors

NCT00658658 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

NCT02963389 ·Status: COMPLETED ·Phase: PHASE1

Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia

NCT01688752 ·Status: WITHDRAWN

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

NCT05135975 ·Status: RECRUITING ·Phase: PHASE2

Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

NCT01974479 ·Status: SUSPENDED ·Phase: PHASE1

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

NCT00001566 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors

NCT04774718 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

NCT02509234 ·Status: UNKNOWN

Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma

NCT03811886 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

NCT03782363 ·Status: WITHDRAWN ·Phase: PHASE1

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

NCT00876031 ·Status: COMPLETED ·Phase: PHASE3

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

NCT03686566 ·Status: COMPLETED

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

NCT06156410 ·Status: RECRUITING ·Phase: PHASE1

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

NCT00001564 ·Status: COMPLETED ·Phase: PHASE2

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

NCT05120518 ·Status: RECRUITING

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

NCT06465199 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

NCT04447755 ·Status: COMPLETED ·Phase: PHASE2

Topotecan Episcleral Plaque for Treatment of Retinoblastoma

NCT04428879 ·Status: COMPLETED ·Phase: PHASE1

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

NCT00978146 ·Status: WITHDRAWN ·Phase: PHASE2

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

NCT07148050 ·Status: RECRUITING ·Phase: PHASE1

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

NCT01225419 ·Status: COMPLETED ·Phase: PHASE2

Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

NCT03611595 ·Status: RECRUITING ·Phase: PHASE1